Application of Machine Learning in Pulmonary Function Assessment Where Are We Now and Where Are We Going?

dc.contributor.author

Giri, Paresh C

dc.contributor.author

Chowdhury, Anand M

dc.contributor.author

Bedoya, Armando

dc.contributor.author

Chen, Hengji

dc.contributor.author

Lee, Hyun Suk

dc.contributor.author

Lee, Patty

dc.contributor.author

Henriquez, Craig

dc.contributor.author

MacIntyre, Neil R

dc.contributor.author

Huang, Yuh-Chin T

dc.date.accessioned

2022-08-26T13:24:56Z

dc.date.available

2022-08-26T13:24:56Z

dc.date.issued

2021-01

dc.date.updated

2022-08-26T13:24:54Z

dc.description.abstract

Analysis of pulmonary function tests (PFTs) is an area where machine learning (ML) may benefit clinicians, researchers, and the patients. PFT measures spirometry, lung volumes, and carbon monoxide diffusion capacity of the lung (DLCO). The results are usually interpreted by the clinicians using discrete numeric data according to published guidelines. PFT interpretations by clinicians, however, are known to have inter-rater variability and the inaccuracy can impact patient care. This variability may be caused by unfamiliarity of the guidelines, lack of training, inadequate understanding of lung physiology, or simply mental lapses. A rules-based automated interpretation system can recapitulate expert's pattern recognition capability and decrease errors. ML can also be used to analyze continuous data or the graphics, including the flow-volume loop, the DLCO and the nitrogen washout curves. These analyses can discover novel physiological biomarkers. In the era of wearables and telehealth, particularly with the COVID-19 pandemic restricting PFTs to be done in the clinical laboratories, ML can also be used to combine mobile spirometry results with an individual's clinical profile to deliver precision medicine. There are, however, hurdles in the development and commercialization of the ML-assisted PFT interpretation programs, including the need for high quality representative data, the existence of different formats for data acquisition and sharing in PFT software by different vendors, and the need for collaboration amongst clinicians, biomedical engineers, and information technologists. Hurdles notwithstanding, the new developments would represent significant advances that could be the future of PFT, the oldest test still in use in clinical medicine.

dc.identifier.issn

1664-042X

dc.identifier.issn

1664-042X

dc.identifier.uri

https://hdl.handle.net/10161/25609

dc.language

eng

dc.publisher

Frontiers Media SA

dc.relation.ispartof

Frontiers in physiology

dc.relation.isversionof

10.3389/fphys.2021.678540

dc.subject

DLCO

dc.subject

artificial intelligence

dc.subject

flow-volume loop

dc.subject

lung volumes

dc.subject

machine learning

dc.subject

pulmonary function test

dc.subject

spirometry

dc.title

Application of Machine Learning in Pulmonary Function Assessment Where Are We Now and Where Are We Going?

dc.type

Journal article

duke.contributor.orcid

Bedoya, Armando|0000-0001-6496-7024

duke.contributor.orcid

Lee, Patty|0000-0001-9906-1628

pubs.begin-page

678540

pubs.organisational-group

Duke

pubs.organisational-group

School of Medicine

pubs.organisational-group

Basic Science Departments

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Biostatistics & Bioinformatics

pubs.organisational-group

Cell Biology

pubs.organisational-group

Medicine

pubs.organisational-group

Pathology

pubs.organisational-group

Medicine, Pulmonary, Allergy, and Critical Care Medicine

pubs.publication-status

Published

pubs.volume

12

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Application of Machine Learning in Pulmonary Function Assessment Where Are We Now and Where Are We Going.pdf
Size:
515.51 KB
Format:
Adobe Portable Document Format